Emergent BioSolutions (EBS) Deferred Taxes (2010 - 2026)

Emergent BioSolutions' Deferred Taxes history runs 17 years deep, the most recent figure standing at -$4.5 million for Q1 2026.

• In Q1 2026, Deferred Taxes fell 124.19% year-over-year to -$4.5 million; the TTM figure through Mar 2026 stood at -$27.1 million (down 207.11% YoY), while the FY2025 annual figure was -$4.0 million, up 27.27% from the prior year.
• Deferred Taxes was -$4.5 million for Q1 2026 at Emergent BioSolutions, down from $1.5 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $22.9 million in Q3 2022 to a low of -$54.1 million in Q4 2022.
• Historically, Deferred Taxes has averaged -$3.0 million across 5 years, with a median of -$400000.0 in 2024.
• The sharpest annual moves came in 2022 and 2025: Deferred Taxes jumped 502.63% in 2022, then tumbled 6850.0% in 2025.
• A 5-year view of Deferred Taxes shows it stood at -$54.1 million in 2022, then surged by 90.39% to -$5.2 million in 2023, then jumped by 92.31% to -$400000.0 in 2024, then jumped by 475.0% to $1.5 million in 2025, then sank by 400.0% to -$4.5 million in 2026.
• The last three Deferred Taxes figures came in at -$4.5 million (Q1 2026), $1.5 million (Q4 2025), and -$10.2 million (Q3 2025), per Business Quant data.